- Home
- PFE vs DHR Comparison
PFE vs DHR Comparison
Compare PFE & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- DHR
- Stock Information
- Founded
- PFE 1849
- DHR 1969
- Country
- PFE United States
- DHR United States
- Employees
- PFE N/A
- DHR N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- DHR Industrial Machinery/Components
- Sector
- PFE Health Care
- DHR Industrials
- Exchange
- PFE Nasdaq
- DHR Nasdaq
- Market Cap
- PFE 149.7B
- DHR 170.9B
- IPO Year
- PFE N/A
- DHR N/A
- Fundamental
- Price
- PFE $26.53
- DHR $244.16
- Analyst Decision
- PFE Buy
- DHR Buy
- Analyst Count
- PFE 13
- DHR 17
- Target Price
- PFE $32.17
- DHR $285.94
- AVG Volume (30 Days)
- PFE 36.3M
- DHR 3.2M
- Earning Date
- PFE 02-04-2025
- DHR 01-29-2025
- Dividend Yield
- PFE 6.48%
- DHR 0.44%
- EPS Growth
- PFE N/A
- DHR N/A
- EPS
- PFE 0.74
- DHR 5.24
- Revenue
- PFE $59,375,000,000.00
- DHR $23,742,000,000.00
- Revenue This Year
- PFE $8.65
- DHR $0.37
- Revenue Next Year
- PFE $0.26
- DHR $5.33
- P/E Ratio
- PFE $35.79
- DHR $46.56
- Revenue Growth
- PFE N/A
- DHR 12.92
- 52 Week Low
- PFE $24.48
- DHR $225.42
- 52 Week High
- PFE $31.54
- DHR $281.70
- Technical
- Relative Strength Index (RSI)
- PFE 51.90
- DHR 61.45
- Support Level
- PFE $25.96
- DHR $232.05
- Resistance Level
- PFE $26.87
- DHR $242.15
- Average True Range (ATR)
- PFE 0.47
- DHR 5.66
- MACD
- PFE -0.03
- DHR 1.25
- Stochastic Oscillator
- PFE 38.20
- DHR 98.05
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
About DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.